Preliminary > Economic Development > Indian Economy and Issues > Pharmaceutical sector
Why in news? The government recently directed all pharmaceutical companies in the country to implement the revised...
Mains > Social justice > Health > Pharmaceutical sector
IN NEWS: Four multilateral agencies have launched a priority research agenda 2023 to better advocate for increase...
Preliminary > Science and Technology > Intellectual Property Rights (IPR) > Pharmaceutical sector
Why in news? The Medicines Patent Pool (MPP) has signed sub-licence agreements with India-based companies, along w...
Preliminary > Science and Technology > Biotechnology > Pharmaceutical sector
Why in news? The Central Government of India has issued a gazette notification banning 14 fixed-dose combination (...
Mains > Social justice > Health > Pharmaceutical sector
IN NEWS: In the recent past, India has been hit by some major pharma concerns. The world largely depends on Indian...
Preliminary > Social Justice > Health > Pharmaceutical sector
Why in news? Recent failures of Indian manufactured drugs overseas have brought attention to the issue of absence ...
Preliminary > Science and Technology > Intellectual Property Rights (IPR) > Pharmaceutical sector
Why in news? The Indian Patent Office has rejected U.S. pharmaceutical giant Johnson & Johnson’s attempt...
Preliminary > Social Justice > Health > Pharmaceutical sector
Why in news? Recently, a controversy came up regarding the marketing strategies of Micro Labs which is a Bengaluru...
Mains > Economic Development > Indian Economy and issues > Pharmaceutical sector
IN NEWS: Recently, the government launched three schemes to strengthen Micro, Small and Medium Enterprises (MSMEs)...
Preliminary > Social Justice > Health > Pharmaceutical sector
Why in news? NPPA increased the prices of as many as 800 essential medicines by 10.7 per cent, effective from Apri...